Sun Pharma Advanced Research Company Limited (BOM:532872)
161.20
+9.70 (6.40%)
At close: May 16, 2025
BOM:532872 Revenue
Sun Pharma Advanced Research Company had revenue of 149.10M INR in the quarter ending December 31, 2024, with 7.58% growth. This brings the company's revenue in the last twelve months to 611.35M, down -42.69% year-over-year. In the fiscal year ending March 31, 2024, Sun Pharma Advanced Research Company had annual revenue of 755.45M, down -68.36%.
Revenue (ttm)
611.35M
Revenue Growth
-42.69%
P/S Ratio
85.31
Revenue / Employee
1.49M
Employees
409
Market Cap
52.15B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 755.45M | -1.63B | -68.36% |
Mar 31, 2023 | 2.39B | 1.02B | 73.98% |
Mar 31, 2022 | 1.37B | -1.16B | -45.74% |
Mar 31, 2021 | 2.53B | 1.76B | 229.31% |
Mar 31, 2020 | 768.14M | -1.06B | -57.99% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,646.93B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,729.85B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,429.39B |
Infosys | 1,647.16B |
Bajaj Finance | 369.88B |
Sun Pharma Advanced Research Company News
- 2 months ago - Stock Market Today: Rajesh Exports, SCI, RHIM, SPARC, and KEC among top 5 gainers on March 20, 2025 - Business Upturn
- 5 months ago - SPARC signs binding LOI with UCSF and Tiller Therapeutics for pre-clinical oncology asset - Business Upturn
- 6 months ago - Sun Pharma Advanced Research Q2 revenue at Rs 12.86 crore; net loss widens to Rs 107.33 crore - Business Upturn